Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Danaher Corp. (DHR)
NYSE:DHR
Holding DHR?
Track your performance easily
DHR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$182.09 - $281.70
Previous Close$271.9
Volume1.05M
Average Volume (3M)2.76M
Market Cap
$200.67B
Enterprise Value$213.38B
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$17.01B
Price to Earnings (P/E)48.4
Beta0.87
Next Earnings
Oct 17, 2024EPS Estimate
$1.57Next Dividend Ex-Date
Sep 27, 2024Dividend Yield0.39%
Share Statistics
EPS (TTM)5.63
Shares Outstanding722,213,081
10 Day Avg. Volume2,449,519
30 Day Avg. Volume2,764,936
Standard Deviation0.07
R-Squared0.37
Alpha0.00523
Financial Highlights & Ratios
Price to Book (P/B)3.94
Price to Sales (P/S)9.32
Price to Cash Flow (P/CF)34.70
P/FCF Ratio43.50
Enterprise Value/Market CapN/A
Enterprise Value/Revenue10.11
Enterprise Value/Gross Profit15.20
Enterprise Value/Ebitda31.68
Forecast
1Y Price Target
$282.53Price Target Upside1.68% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering15
Danaher News
PremiumPress Releases
Danaher Announces Quarterly Dividend
Bulls Say, Bears Say
Bulls Say
Financial PerformanceDHR aims for high single-digit long-term growth in its Diagnostics segment, with innovation, menu expansion, and market execution as key drivers.
Growth OpportunitiesDHR plans over 20 new assay launches in the next 5 years, targeting major opportunities in non-respiratory markets such as oncology, hospital-acquired infections, and women's health.
Strategic PositioningDHR's repositioning strategy to emphasize growth and innovation at a platform level is expected to unlock new diagnostic areas and optimize the existing portfolio's potential.
Bears Say
Growth ExpectationsThere is more downside than upside risk to 2025 consensus expectations and with valuation at a premium, the recommendation is initiated at Equal Weight.
Market PerformanceLife Sciences markets remain weak, with Instruments and select areas of consumables being challenged.
ValuationThe main concern is valuation, with shares trading at a 30% premium to Tools, near the Covid-era peak spread, making the risk/reward seem balanced.
---
Ownership Overview
9.41% Insiders
29.66% Mutual Funds
38.91% Other Institutional Investors
22.02% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Legal & RegulatoryLitigation, compliance, new legislation, and taxation risks
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
DHR FAQ
What was Danaher Corp.’s price range in the past 12 months?
Danaher Corp. lowest stock price was $182.09 and its highest was $281.70 in the past 12 months.
What is Danaher Corp.’s market cap?
Currently, no data Available
When is Danaher Corp.’s upcoming earnings report date?
Danaher Corp.’s upcoming earnings report date is Oct 17, 2024 which is in 28 days.
How were Danaher Corp.’s earnings last quarter?
Danaher Corp. released its earnings results on Jul 23, 2024. The company reported $1.72 earnings per share for the quarter, beating the consensus estimate of $1.573 by $0.147.
Is Danaher Corp. overvalued?
According to Wall Street analysts Danaher Corp.’s price is currently Undervalued.
Does Danaher Corp. pay dividends?
Danaher Corp. pays a Quarterly dividend of $0.27 which represents an annual dividend yield of 0.39%. See more information on Danaher Corp. dividends here
What is Danaher Corp.’s EPS estimate?
Danaher Corp.’s EPS estimate is $1.57.
How many shares outstanding does Danaher Corp. have?
Danaher Corp. has 722,213,100 shares outstanding.
What happened to Danaher Corp.’s price movement after its last earnings report?
Danaher Corp. reported an EPS of $1.72 in its last earnings report, beating expectations of $1.573. Following the earnings report the stock price went up 5.297%.
Which hedge fund is a major shareholder of Danaher Corp.?
Among the largest hedge funds holding Danaher Corp.’s share is Fisher Asset Management LLC. It holds Danaher Corp.’s shares valued at 1B.
---
Danaher Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$282.53 (1.68% Upside)
$282.53 (1.68% Upside)
Blogger Sentiment
Bullish
DHR Sentiment 93%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 3.2M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $12.4M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Neutral
Last 7 Days ▼ 0.5%
Last 30 Days ▲ 1.4%
Last 30 Days ▲ 1.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
21.41%
12-Months-Change
Fundamentals
Return on Equity
8.36%
Trailing 12-Months
Asset Growth
-7.48%
Trailing 12-Months
Company Description
Danaher Corp.
Founded in 1969 and headquartered in Washington, DC, Danaher Corp. engages in manufacturing, designing and marketing of professional, medical, industrial and commercial products and services. The company operates through three segments, including Life Sciences, Diagnostics, and Environmental & Applied Solutions.
---
DHR Company Deck
---
DHR Earnings Call
Q2 2024
0:00 / 0:00
---
DHR Revenue Breakdown
40.09% Diagnostics
30.02% Biotechnology
29.89% Life Sciences
---
DHR Stock 12 Month Forecast
Average Price Target
$282.53
▲(1.68% Upside)
Technical Analysis
Best Analysts Covering DHR
1 Year
1 Year Success Rate
7/8 ratings generated profit
1 Year Average Return
+13.50%
assigned a buy rating 2 months ago
Copying Justin Bowers's trades and holding each position for 1 Year would result in 87.50% of your transactions generating a profit, with an average return of +13.50% per trade.
---